ISONEA LIMITED (ASX:ISN)
Industry:
Activity: Medical research and development company
1233 High Street Suite 1 ARMADALE VIC 3143
Ph: +61 (0)3 9824 5254    Fax: +61 (0)3 9822 7735
Michael Thomas
Thu, 9 Aug 2012 9:45am
Mr Michael Thomas, CEO
Michael Thomas
Wed, 8 Aug 2012 9:45am
Mr Michael Thomas, CEO
Michael Thomas
Tue, 27 Mar 2012 10:30am
Mr Michael Thomas, CEO
Michael Thomas
Thu, 22 Mar 2012 1:30pm
Michael Thomas, CEO
Michael Thomas
Thu, 8 Dec 2011 10:00am
Michael Thomas, CEO
Michael Thomas
Fri, 7 Oct 2011 9:30am
Michael Thomas, CEO
Icon_lastIcon_nextIcon_previousIcon_first
Interim Results
Thu, 28 Feb 2013
Annual General Meeting
Thu, 15 Nov 2012
Full Year Results
Fri, 31 Aug 2012
Quarterly Production Date
Wed, 1 Aug 2012
Quarterly Sales Date
Wed, 1 Aug 2012
Quarterly Sales Date
Mon, 30 Apr 2012
Interim Results
Wed, 29 Feb 2012
Annual General Meeting
Thu, 17 Nov 2011
Response to Price Query Wed, 15 May 2013
Appendix 4C - Third Quarter Cash Report and Investor Update Tue, 30 Apr 2013
iSonea Newsletter - Edition 4 - April 2013 Mon, 22 Apr 2013
iSonea Investor Presentation - April 2013 Mon, 22 Apr 2013
iSonea CEO to Present at Investor Forum on 24 April 2013 Mon, 22 Apr 2013
Appendix 3B & Section 708A Notice Wed, 17 Apr 2013
Appendix 3Y - Change of Director's Interest Notice (DD) Tue, 16 Apr 2013
iSonea Launches New AsthmaSense Cloud Technology Fri, 12 Apr 2013
Unveiling New Asthma Technology at Aust Asthma Conference Tue, 19 Mar 2013
iSonea Unveils Regulatory Plans for AirSonea Wheeze Monitor Fri, 8 Mar 2013

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. BRR Media does not claim any association with any company listed on this site.